Gene · 2160
Papers2,705
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,705
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting Factor XI for Safer Anticoagulation: Emerging Data and Future Directions. | Am J Cardiovasc Drugs | 2026 | 41581095 | PubTator, text mining | PubMed |
| ROTEM-detected hypocoagulability is associated with major non-portal hypertensive bleeding in cirrhosis. | Hepatol Commun | 2026 | 41564385 | PubTator, text mining | PubMed |
| Association Between High-Density Lipoprotein Characteristics and Hemostatic Parameters in the Netherlands Epidemiology of Obesity (NEO) Study-Brief Report. | Arterioscler Thromb Vasc Biol | 2026 | 41564160 | PubTator, text mining | PubMed |
| Rare Bleeding Disorders: Strategy for Diagnosis and Management- A Tertiary Care Experience from North India. | Indian J Hematol Blood Transfus | 2026 | 41522530 | PubTator, text mining | PubMed |
| RNA interference therapy targeting coagulation factor XI: a first-in-human trial of RBD4059 (vortosiran). | Blood Adv | 2026 | 41512172 | PubTator, text mining | PubMed |
| Identification of potential therapeutic targets for stroke and its subtypes by integrating proteomes and genetics from human plasma. | Brain Commun | 2026 | 41488603 | PubTator, text mining | PubMed |
| Non-linear association of coagulation factor XI with mortality. | Med | 2026 | 41455467 | PubTator, text mining | PubMed |
| Genome-wide identification of loci associated with plasma coagulation factor IX activity. | J Thromb Haemost | 2026 | 41161418 | PubTator, text mining | PubMed |
| Elevated Factor XI is Associated with First and Recurrent Left Atrial Appendage Thrombus of Unknown Origin. | Thromb Haemost | 2026 | 41022131 | PubTator, text mining | PubMed |
| Prevalence of haemostatic genes' polymorphisms in men and women with venous thromboembolism in the Czech Republic - a population-based study of cases and controls. | Cas Lek Cesk | 2025 | 41582910 | PubTator, text mining | PubMed |
| Development of a MassARRAY Genotyping Platform and Its Clinical Application for Venous Thromboembolism Risk Assessment in Thai Patients. | Med Sci (Basel) | 2025 | 41440514 | PubTator, text mining | PubMed |
| Thrombosis Caused by Factor XI Gly397Ser Mutation with Enhanced Procoagulant Activity. | Thromb Haemost | 2025 | 41360087 | PubTator, text mining | PubMed |
| Coagulation factor XI and coronary artery disease: is there room for factor XI inhibitors? | Pol Arch Intern Med | 2025 | 41312611 | PubTator, text mining | PubMed |
| Insights from the Evolution of Coagulation: A New Perspective on Anti-Inflammatory Strategies in the ICU-Focus on the Contact Activation System. | Biomedicines | 2025 | 41301820 | PubTator, text mining | PubMed |
| Capillary leak syndrome in sepsis: the role of intrinsic coagulation pathway activation. | BMC Infect Dis | 2025 | 41286650 | PubTator, text mining | PubMed |
| Efficacy and safety of REGN9933A2 and REGN7508Cat for preventing postoperative venous thromboembolism (ROXI-VTE-I and ROXI-VTE-II): two randomised, open-label, phase 2 trials. | Lancet | 2025 | 41218619 | PubTator, text mining | PubMed |
| Multiomics reveal plasma constituents associated with thrombosis among trauma patients who do not respond to enoxaparin. | Blood Vessel Thromb Hemost | 2025 | 41210697 | PubTator, text mining | PubMed |
| Laboratory and Clinical Analysis of Rare Coagulation Factor Deficiencies-A Respective Study of a Single Center from Northwest China. | Clin Appl Thromb Hemost | 2025 | 41197140 | PubTator, text mining | PubMed |
| Proteome-wide Mendelian randomization and colocalization analysis uncovers druggable targets for lung cancer across multiple phenotypes and complications. | Discov Oncol | 2025 | 41196451 | PubTator, text mining | PubMed |
| Clinical and Genetic Characterization of Factor XI Deficiency in Jordan: Identification of a Novel Splice-Site Mutation Associated with Severe Deficiency. | Clin Appl Thromb Hemost | 2025 | 41124306 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2160/papers?page=5